Cargando…

1309. Incidence and Epidemiology of Invasive Pneumococcal Disease due to Serotype 3 in South-Central Ontario

BACKGROUND: In our population, the most common serotype (ST) of S. pneumoniae causing invasive pneumococcal disease (IPD) is now ST 3. We undertook an analysis of population based surveillance for IPD to examine the incidence and epidemiology of ST 3 disease over the last 25 years. METHODS: The Toro...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGeer, Allison, Plevneshi, Agron, Hassan, Kazi, Gold, Wayne, Matukas, Larissa, Mazzulli, Tony, Richardson, David, Lovinsky, Reena, Martin, Irene, Katz, Kevin, Baqi, Mahin, Walmsley, Sharon, Vermeiren, Christie, Shigayeva, Altynay, Zhong, Zoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644871/ http://dx.doi.org/10.1093/ofid/ofab466.1501

Ejemplares similares

2606. Epidemiology of invasive pneumococcal disease in adults with and without underlying lung disease in Ontario, Canada
por: Zhong, Zoe, et al.
Publicado: (2023)

295. Is Herd Immunity from Pneumococcal Conjugate Vaccines Changing the Clinical Features of Invasive Pneumococcal Disease in Adults?
por: McGeer, Allison, et al.
Publicado: (2020)

2716. Persistence of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Serotypes in Invasive Pneumococcal Disease in Adults in Southern Ontario Canada Despite Routine Pediatric Vaccination
por: McGeer, Allison, et al.
Publicado: (2019)

1426. Impact of Routine Pediatric PCV13 on the Incidence and Severity of Invasive Pneumococcal Disease in Adults in Ontario, Canada
por: Nayani, Sarah, et al.
Publicado: (2018)

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50–64 Years, 2010–2011 to 2016–2017
por: Kim, Philip, et al.
Publicado: (2022)

Changing Epidemiology of Invasive Pneumococcal Disease due to Conjugate Vaccine Serotypes in Toronto, Canada After Introduction of a Routine Pediatric PCV13 Program
por: Mcgeer, Allison, et al.
Publicado: (2017)

2401. Risk Factors for Antimicrobial Resistance in Invasive Pneumococcal disease (IPD) in Toronto, Canada, 2012–2017
por: Fear, Thomas, et al.
Publicado: (2018)

Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto
por: Plevneshi, Agron, et al.
Publicado: (2009)

462. Prospective Surveillance of Invasive Group A Streptococcal Infections in Toronto, Ontario, Canada: 1992–2017
por: Kandel, Christopher, et al.
Publicado: (2019)

1475. Impact of a Routine Infant PCV Program on the Serotype Distribution of Episodes of Invasive Pneumococcal Disease (IPD) and Non-bacteremic Pneumococcal Pneumonia in Adults
por: McGeer, Allison
Publicado: (2020)

Patient Contact Recall after SARS Exposure
por: Dimoulas, Popy, et al.
Publicado: (2005)

2468. The Genomic Epidemiology of Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada, 2016
por: Jamal, Alainna J, et al.
Publicado: (2023)

Whole-genome Sequencing for Surveillance of Invasive Pneumococcal Diseases in Ontario, Canada: Rapid Prediction of Genotype, Antibiotic Resistance and Characterization of Emerging Serotype 22F
por: Deng, Xianding, et al.
Publicado: (2016)

1186. Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains in Southern Ontario
por: Jamal, Alainna, et al.
Publicado: (2018)

Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia
por: Kohler, Philipp, et al.
Publicado: (2018)

The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
por: Wijayasri, Shinthuja, et al.
Publicado: (2019)

Correction to Lancet Oncol 2020; 21: 1309–16
Publicado: (2020)

Population Structure and Antimicrobial Resistance of Invasive Serotype IV Group B Streptococcus, Toronto, Ontario, Canada
por: Teatero, Sarah, et al.
Publicado: (2015)

Use of whole genome sequencing to identify low‐frequency mutations in SARS‐CoV‐2 patients treated with remdesivir
por: Nirmalarajah, Kuganya, et al.
Publicado: (2023)

1309. Fungal Prosthetic Joint Infection - Case Series and Review of the Literature
por: Starnes, Victoria, et al.
Publicado: (2023)

The Clinical Burden of Clostridioides difficile in Ontario, Canada
por: Pereira, Jennifer A, et al.
Publicado: (2019)

When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto
por: Kuster, Stefan P, et al.
Publicado: (2011)

Characterization of culture-positive adenovirus serotypes from respiratory specimens in Toronto, Ontario, Canada: September 2007–June 2008
por: Yeung, Rani, et al.
Publicado: (2009)

Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses
por: Kandel, Christopher, et al.
Publicado: (2022)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
por: Linley, Ezra, et al.
Publicado: (2019)

Draft Genome Sequence of Enterococcus faecalis UMB1309, Isolated from Catheterized Urine
por: Schwartz, Adam, et al.
Publicado: (2020)

Pneumococcal serotype evolution in Western Europe
por: Tin Tin Htar, Myint, et al.
Publicado: (2015)

Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009–May 2010
por: Achonu, Camille, et al.
Publicado: (2011)

Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada
por: Kuster, Stefan P., et al.
Publicado: (2013)

Persistence of Pneumococcal Serotype 3 in Adult Pneumococcal Disease in Hong Kong
por: Subramanian, Reema, et al.
Publicado: (2021)

89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada
por: Mozafarihashjin, Mohammad, et al.
Publicado: (2022)

Optimal Serotype Compositions for Pneumococcal Conjugate Vaccination under Serotype Replacement
por: Nurhonen, Markku, et al.
Publicado: (2014)

Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
por: Johnson, Hope L., et al.
Publicado: (2010)

Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice
por: Quesada, Carlos F., et al.
Publicado: (1998)

Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
por: Cui, Yingzi, et al.
Publicado: (2021)

1468. PCV13 Serotype Trends Over Time in Pneumococcal Community Acquired Pneumonia: Which Method(s) Work Best?
por: Leblanc, Jason, et al.
Publicado: (2018)

Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing
por: Demczuk, Walter H. B., et al.
Publicado: (2017)

Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study
por: Volling, Cheryl, et al.
Publicado: (2014)

Pediatric Pneumococcal Serotypes in 4 European Countries
por: Hanquet, Germaine, et al.
Publicado: (2010)

Production of latex agglutination reagents for pneumococcal serotyping
por: Ortika, Belinda D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oj99f9rkvm1e3cm153kgd8cch6